The scientific community is carefully watching this innovative therapy, a dual-action therapy targeting both glucose metabolism and another incretin hormone. Initial research suggest it could offer meaningful benefits in obesity management compared to existing medications, possibly representing a significant advance in the battle of a challengin… Read More